PPMS Onset Upon Adalimumab Treatment Extends the Spectrum of Anti-TNF-Α Therapy-Associated Demyelinating Disorders
Therapeutic Advances in Neurological Disorders - United Kingdom
doi 10.1177/1756286419895155
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
SAGE Publications